ArticleJournal of the National Cancer Institute2021

Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea.

Kathryn J Ruddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.